MAPT and Alzheimer disease: This table highlights key microbial metabolites that influence AD pathogenesis by modulating neuroinflammation, amyloid and tau pathology, BBB integrity, and oxidative stress, and serve as promising biomarkers for diagnosis and prognosis.